Immune thrombocytopenia (ITP): vizsgálatok itt: Spanyolország
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Where
- Barcelona, Burgos, Madrid, Murcia, Palma, Salamanca, San Cristóbal de La Laguna, Sevilla
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00 - 1/2. fázisTaking peopleTGD001 Treatment in Thrombotic Microangiopathies
- Where
- Valencia
- Életkor
- 18 év and over
- People
- 70
- Run by
- TargED Biopharmaceuticals B.V.
See details and how to joinNCT07459114 - 1/2. fázisTaking peopleA Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Where
- Barcelona, Burgos, Madrid, Murcia, Pamplona
- Életkor
- 18 év to 64 év
- People
- 68 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00 - 3. fázisTaking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Alcorcón, Madrid, Salamanca, Sevilla
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 1. fázisTaking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Barcelona, Córdoba, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - 3. fázisTaking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Alcorcón, Burgos, Madrid, Salamanca, Sevilla
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 2. fázisTaking peopleStudy to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Where
- Badalona, Madrid
- Életkor
- 18 év and over
- People
- 56 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00 - 3. fázisTaking peopleA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- Where
- A Coruña, Madrid
- Életkor
- 18 év to 70 év
- People
- 40 worldwide
- Run by
- Kedrion S.p.A.
See details and how to joinNCT07059000 · EU 2023-507115-35-00 - 1/2. fázisTaking peopleSafety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Where
- Barcelona, Córdoba, Madrid, Seville
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07549698 - 2/3. fázisTaking peopleA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Where
- Barcelona, Esplugues de Llobregat, Madrid, Sabadell, Zaragoza
- Életkor
- 12 év to 17 év
- People
- 24 worldwide
- Run by
- argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00 - 2. fázisTaking peopleSafety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
- Where
- Barcelona, Burgos, Murcia, Salamanca
- Életkor
- 18 év to 80 év
- People
- 30 worldwide
- Run by
- Nuvig Therapeutics, Inc.
See details and how to joinNCT07095127 · EU 2024-520359-26-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Barcelona, Córdoba, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Barcelona, Córdoba, Madrid, Pamplona, Seville, Valencia
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pozuelo de Alarcón, Valencia
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00 - 1/2. fázisTaking peopleA Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
- Where
- Burgos, Madrid, San Pedro, Valencia
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07043946 - No phaseTaking peopleRESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
- Where
- A Coruña, Algeciras, Barcelona, Bilbao, Cadiz, Castellon, Córdoba, Granada, Huelva, Jaén, Jerez de la Frontera, Lleida, Lugo, Madrid, Málaga, Marbella, Osuna, Oviedo, Palma, Pamplona, Ronda, Salamanca, Santa Cruz de Tenerife, Seville, Terrassa, Torrelavega, Valencia, Zaragoza
- Életkor
- 2 hónap and over
- People
- 1000
- Run by
- Fundación Española de Hematología y Hemoterapía
See details and how to joinNCT06919341